Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA

Summary

Dermal fibroblasts from a patient carrying a heterozygous c.88G > C mutation in the SNCA gene that encodes alpha-synuclein were reprogrammed to pluripotency by retroviruses. This pathogenic mutation generates the p.A30P form of the alpha-synuclein protein leading to autosomal dominantly inherited Parkinson's disease (PD). Two clonal iPS cell lines were generated (A30P-3 and A30P-4) and characterised by validating the silencing of viral transgenes, the expression of endogenous pluripotency genes, directed differentiation into three germ layers in-vitro and a stable molecular genotype. These iPSC lines will serve as a valuable resource in determining the role of the p.A30P SNCA mutation in PD pathogenesis. Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Barbuti PA, Santos BFR, Dording CM, Cruciani G, Massart F, Hummel A, Krüger R
Journal Stem cell research
Publication Date 2020 Aug 8;48:101951
PubMed 32798915
DOI 10.1016/j.scr.2020.101951

Research Projects

Cell Lines